Ivan S Pradipta
Overview
Explore the profile of Ivan S Pradipta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahar M, Kausar M, Khairunnisa K, Pradipta I
Prim Health Care Res Dev
. 2025 Jan;
26:e7.
PMID: 39849322
Background: Community pharmacists should provide qualified drug information services for the rational use of medicine in community. However, there is no standard professional incentive for the service in Indonesia. This...
2.
Iskandar D, Pradipta I, Anggriani A, Postma M, van Boven J
BMJ Open Respir Res
. 2023 Nov;
10(1).
PMID: 37949612
Introduction: Optimal pharmacological treatment of tuberculosis (TB) requires a multidisciplinary team, yet the hospital pharmacist's role is unclear. We aimed to analyse hospital pharmacist-provided clinical pharmacy services (CPS) implementation in...
3.
Alfian S, Khoiry Q, Andhika A Pratama M, Pradipta I, Kristina S, Zairina E, et al.
BMC Med Educ
. 2023 Oct;
23(1):800.
PMID: 37884985
Introduction: The coronavirus disease 2019 (COVID-19) pandemic accelerated the provision of telepharmacy services. However, little is known about the knowledge, perception, and willingness of pharmacy students as future key players...
4.
Iskandar D, Suwantika A, Pradipta I, Postma M, van Boven J
Lancet Glob Health
. 2022 Nov;
11(1):e117-e125.
PMID: 36435182
Background: The global incidence of tuberculosis is decreasing, yet it remains high in Indonesia. The Indonesian National Tuberculosis Program facilitates mandatory notification, which enables early detection and treatment, minimises complications,...
5.
Pradipta I, Idrus L, Probandari A, Puspitasari I, Santoso P, Alffenaar J, et al.
Front Pharmacol
. 2022 Apr;
13:857783.
PMID: 35401200
Community health centers (CHCs) are a backbone healthcare facility for tuberculosis (TB) services. Identifying barriers amongst TB service providers at the CHC level is required to help them deliver successful...
6.
Ridho A, Alfian S, van Boven J, Levita J, Yalcin E, Le L, et al.
J Med Internet Res
. 2022 Feb;
24(2):e33062.
PMID: 35195534
Background: Nonadherence to medication in tuberculosis (TB) hampers optimal treatment outcomes. Digital health technology (DHT) seems to be a promising approach to managing problems of nonadherence to medication and improving...
7.
Pradipta I, Idrus L, Probandari A, Lestari B, Diantini A, Alffenaar J, et al.
BMC Public Health
. 2021 Oct;
21(1):1903.
PMID: 34670527
Background: Previously treated tuberculosis (TB) patients are a widely reported risk factor for multidrug-resistant tuberculosis. Identifying patients' problems during treatment is necessary to control TB, especially in a high-burden setting....
8.
Pradipta I, Houtsma D, van Boven J, Alffenaar J, Hak E
NPJ Prim Care Respir Med
. 2020 May;
30(1):21.
PMID: 32393736
Non-adherence to anti-tuberculosis (anti-TB) medication is a major risk factor for poor treatment outcomes. We therefore assessed the effectiveness of medication adherence enhancing interventions in TB patients. We report a...
9.
Pradipta I, Vant Boveneind-Vrubleuskaya N, Akkerman O, Alffenaar J, Hak E
Antimicrob Resist Infect Control
. 2019 Jul;
8:115.
PMID: 31338162
Background: Since in low incidence TB countries population migration and complex treatment of drug-resistant tuberculosis (DR-TB) patients are major issues, we aimed to analyse patient risk factors associated with the...
10.
Alfian S, Pradipta I, Hak E, Denig P
J Clin Epidemiol
. 2018 Dec;
108:44-53.
PMID: 30537541
Objectives: We reviewed measures used to estimate adherence and persistence to multiple cardiometabolic medications from prescription data, particularly for blood pressure-lowering, lipid-lowering, and/or glucose-lowering medication, and give guidance on which...